| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |